Creative Biolabs Established SuPrecision™ Platform to Upgrade Sequencing Services

NEW YORK, USA, July 18, 2019—As a biotechnology company with a high reputation, Creative Biolabs is dedicated to providing sequencing services, especially cancer screening. Having accumulated rich sequencing experience, the company formed a series of sequencing services with unique characteristics. Recently, the establishment of SuPrecision™ platform ushers in the new era of cancer sequencing services at this company.

The SuPrecision™ platform is of high throughput. That means large-scale sequencing services are available to accelerate the development of cancer diagnosis and precision medicine. Based on this cutting-edge platform, the upgradation of sequencing services such as whole transcriptome sequencing, whole genome sequencing, whole exome sequencing, etc., effectively accelerates the sequencing process and improves the result accuracy at the same time.

Whole transcriptome sequencing

Whole transcriptome sequencing, an important tool for basic research, clinical diagnosis and drug researches and development, can rapidly obtain comprehensive information on almost all transcript sequences of a particular tissue or organ. Creative Biolabs well understands clients’ demands and upgraded the whole transcriptome sequencing service for cancer researches relying on the SuPrecision™ Platform, including library preparation, high-throughput sequencing, and bioinformatics analysis.

Compared with the old way based on microarray technologies, the whole transcriptome sequencing service will help analyze novel genes and transcripts, thus finding new gene’s functions. Besides, the analysis of tumor microenvironment will help related researches. In addition, all RNAs can be investigated, allowing the study of isoforms, splice variants, and fusion transcripts. 

DNA sequencing 

It is known that DNA sequencing technology not only enhances genetic researches but also assists with the examination of various genetic diseases, especially cancers. There are two main ways to sequence DNA: whole exome sequencing and whole genome sequencing, which are regarded as the next-generation sequencing. 

Whole exome sequencing services for cancer can detect variations in protein coding regions of all gene services. With a comprehensive bioinformatics pipeline, elaborate workflow and comprehensive analysis based on SuPrecision™ Platform, it is easy to sequence large amounts of exomes and offer the accurate data report. On the other hand, Creative Biolabs accepts purified genomic DNA and frozen cell pellets and formalin-fixed paraffin-embedded (FFPE) thin tissue sections as the starting material for whole exome sequencing.

Though whole exome sequencing is a good way to sequence DNA, gene activity can also be affected by DNA sequences outside the exon region, which is beyond the sequencing range of whole exome sequencing. Therefore, Creative Biolabs launched whole genome sequencing for cancers as a supplement to help obtain the sequence of all the DNA nucleotides of an individual, thus detecting any gene variations. 

With the cutting-edge SuPrecision™ platform, whole genome sequencing for cancers is able to detect DNA modifications without bisulfite treatment and all the analysis results are of high accuracy up to 99.99%. In addition, professional scientists will offer technical support. 

Moreover, the RNA library kit is also available at Creative Biolabs. Depending on the cancer sequencing method, the RNA library prep kit is ideal for high-quality library generation. Types of the kits mainly include SuR mRNA-seq v2 Library Prep Kit for Illumina®, SuR RNA Adapters set1/set2 for Illumina®, etc. For more kit details, please visit:

About the company

Creative Biolabs never forgets to push the boundaries of science to offer sequencing services to promote the development of cancer research and the relative medical research process. It is customer-oriented and the driving philosophy is to provide more professional services and accurate data reports. For more information about sequencing services, please visit:

Media Contact
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email
Phone: 1-631-619-7922
Address:45-1 Ramsey Road
City: Shirley
State: New York
Country: United States